To illustrate, a more definite timeline of disease and pathway dysfunction during synucleinopathy progression, the identification of native and toxic α-synuclein isoforms in healthy and affected subjects, and the characterization of α-synuclein’s propagation could be crucial. Here, SNCA is linked to synucleinopathy.